Anti-Infliximab ELISA Kit (AF879028)

Overview

Catalog No.	AF879028
Description	Anti-Infliximab ELISA Kit (AF879028) — Quantitative sandwich ELISA for Anti-Infliximab. Sample: Plasma, Serum. Range: 156.25 - 10, 000 ng/mL. Highlights ●Sandwich Format — High specificity, reliable quantification. ●Ready-to-Use — Complete kit with pre-coated plates included.
Sample type	Serum, plasma, and other biological fluid samples
Sensitivity	0.37 ng/mL
Range	1.56 - 100 ng/mL
Species reactivity	Human
Target	TNFa/TNF-alpha
Accession	P01375
Applications	ELISA
Detection method	Colorimetric
Assay type	Sandwich
Recovery	80-120%
Shipping	2-8 ℃
Stability and Storage	The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Specifications	Infliximab
Alternate Names	TA-650, cA2, 170277-31-3
Background	Infliximab is a chimeric monoclonal antibody and used to treat auto- immune disorders. Infliximab reduces the amount of active human tumour necrosis factor alpha (hTNFa) in the body by binding to it and preventing it from signaling the receptors for TNFa on the surface of various cell types. TNFa is one of the key cytokines that triggers and sustains the inflammatory reactions. Infliximab is used for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis.
Note	For Research Use Only.

Images

References

Datasheet

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Overview